- Bloomberg•3 hours ago
England is reopening its Cancer Drugs Fund with a crafty solution to rein in the overspending that blighted its predecessor: make drugmakers pay.
- Market Realist•yesterday
After the earnings results, analysts updated Roche's consensus 12-month target price to $36.85 from the $37.2 pre-earnings price.
|52wk Range||29.89 - 36.49|
|Day's Range||31.30 - 31.73|
|Avg Vol (3m)||992,685|
As of 3:59 PM EDT. Market closed.